Exploring Micromonospora as Phocoenamicins Producers
Authors:
- Maria KokkiniMaria Kokkini
- Cristina González HerediaCHCristina González Heredia
- Daniel Oves-CostalesDODaniel Oves-Costales
- Mercedes de la CruzMCMercedes de la Cruz
- Pilar SánchezPSPilar Sánchez
- Jesús MartínJMJesús Martín
- Francisca VicenteFVFrancisca Vicente
- Olga GenilloudOGOlga Genilloud
- Fernando ReyesFernando Reyes
Open Access
- 7 December 2022
- journal article
- research article
- Published by MDPI AG in Marine Drugs
- Vol. 20 (12) , 769
Abstract
Over the past few years, new technological and scientific advances have reinforced the field of natural product discovery. The spirotetronate class of natural products has recently grown with the discovery of phocoenamicins, natural actinomycete derived compounds that possess different antibiotic activities. Exploring the MEDINA’s strain collection, 27 actinomycete strains, including three marine-derived and 24 terrestrial strains, were identified as possible phocoenamicins producers and their taxonomic identification by 16S rDNA sequencing showed that they all belong to the Micromonospora genus. Using an OSMAC approach, all the strains were cultivated in 10 different media each, resulting in 270 fermentations, whose extracts were analyzed by LC-HRMS and subjected to High-throughput screening (HTS) against methicillin-resistant Staphylococcus aureus (MRSA), Mycobacterium tuberculosis H37Ra and Mycobacterium bovis. The combination of LC-UV-HRMS analyses, metabolomics analysis and molecular networking (GNPS) revealed that they produce several related spirotetronates not disclosed before. Variations in the culture media were identified as the most determining factor for phocoenamicin production and the best producer strains and media were established. Herein, we reported the chemically diverse production and metabolic profiling of Micromonospora sp. strains, including the known phocoenamicins and maklamicin, reported for the first time as being related to this family of compounds, as well as the bioactivity of their crude extracts. Although our findings do not confirm previous statements about phocoenamicins production only in unique marine environments, they have identified marine-derived Micromonospora species as the best producers of phocoenamicins in terms of both the abundance in their extracts of some major members of the structural class and the variety of molecular structures produced.Keywords
Funding Information
- European Commission (721421)
This publication has 57 references indexed in Scilit:
- Siderophore production by actinobacteriaBioMetals, 2014
- Balibalosides, an Original Family of Glucosylated Sesterterpenes Produced by the Mediterranean Sponge Oscarella balibaloiMarine Drugs, 2013
- Chrolactomycins from the Actinomycete ActinospicaJournal of Natural Products, 2012
- Maklamicin, an Antibacterial Polyketide from an Endophytic Micromonospora sp.Journal of Natural Products, 2011
- MZmine 2: Modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile dataBMC Bioinformatics, 2010
- MassBank: a public repository for sharing mass spectral data for life sciencesJournal of Mass Spectrometry, 2010
- Genetic Characterization of the Chlorothricin Gene Cluster as a Model for Spirotetronate Antibiotic BiosynthesisChemistry & Biology, 2006
- Big Effects from Small Changes: Possible Ways to Explore Nature's Chemical DiversityChemBioChem, 2002
- A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening AssaysSLAS Discovery, 1999
- Leptomycins A and B, new antifungal antibiotics. II. Structure elucidation.The Journal of Antibiotics, 1983